Gaucher Disease Clinical Trials

A listing of Gaucher Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Sacramento California 95825

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Florida

UPDATED

Miami Florida 33014

Patients are needed to participate in a clinical research study evaluating Eliglustat for the treatment of Gaucher Disease

Miami Florida 33014

A Phase 1 clinical study for patients with Gaucher Disease

Tampa Florida 33606

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Indiana

Evansville Indiana 47710

A Phase 1 clinical study for patients with Gaucher Disease

Massachusetts

Boston Massachusetts 02115

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Minnesota

St. Paul Minnesota 55144

A Phase 1 clinical study for patients with Gaucher Disease

Montana

Helena Montana 59601

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

New Jersey

Morristown New Jersey 07960

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Paterson New Jersey 07503

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Ohio

Cleveland Ohio 44195

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Dublin Ohio 43017

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Tennessee

UPDATED

Knoxville Tennessee 37920

Patients are needed to participate in a clinical research study evaluating Eliglustat for the treatment of Gaucher Disease

Knoxville Tennessee 37920

A Phase 1 clinical study for patients with Gaucher Disease

Algeria

Oran 31000

A clinical study for patients with Lysosomal Storage Diseases, Gaucher Disease or Sphingolipidoses

Australia

Adelaide 5000

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Parkville 3050

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Austria

Salzburg A-5020

A clinical study for patients with Gaucher's Disease

Wien A-1090

A clinical study for patients with Gaucher's Disease

Wien A-1090

A clinical study for patients with Gaucher's Disease

Brazil

Porto Alegre 90035-003

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Sao Paulo 04024-002

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Sao Paulo 14048-900

A clinical study for patients with Lysosomal Storage Diseases, Gaucher Disease or Sphingolipidoses

Canada

Halifax B3K6R8

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Montreal H3T 1E2

A clinical trial seeking patients for a research study for the treatment of Gaucher's Disease

China

Beijing

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Egypt

Ash Sharqia

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Cairo

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Cairo

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Cairo

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

France

Angers 49033

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Angers 49033

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Montpellier 34059

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Montpellier 34059

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

TOURS Cedex 9 37044

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

Germany

Erlangen D-91054

A clinical study for patients with Gaucher's Disease

Hamburg D-22607

A clinical study for patients with Gaucher's Disease

Kirn 55606

A clinical study for patients with Gaucher's Disease

Mainz 55131

A clinical study for patients with Gaucher's Disease

Mühlhausen D-92360

A clinical study for patients with Gaucher's Disease

View More ▼

Munich D-81675

A clinical study for patients with Gaucher's Disease

Rostock D-18147

A clinical study for patients with Gaucher's Disease

Rostock 18147

A clinical study for patients with Lysosomal Storage Diseases, Gaucher Disease or Sphingolipidoses

Rostock 18147

Patients are needed to participate in a clinical research study for the treatment of Lysosomal Storage Diseases, Gaucher Disease or Sphingolipidoses

Schwerin D-19055

A clinical study for patients with Gaucher's Disease

Ulm 89075

A clinical study for patients with Gaucher's Disease

Greece

Thessaloniki 54642

A clinical study for patients with Lysosomal Storage Diseases, Gaucher Disease or Sphingolipidoses

Hong Kong

Kowloon

A clinical study for patients with Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease or Glucosylceramide Beta-Glucosidase Deficiency Disease

India

Mumbai 400705

A clinical study for patients with Lysosomal Storage Diseases, Gaucher Disease or Sphingolipidoses

Iran, Islamic Republic of

Tehran

Patients are needed to participate in a clinical research study for the treatment of Lysosomal Storage Diseases, Gaucher Disease or Sphingolipidoses